Tocoflexol Synthesis for Extended Half-Life and Alpha-TTP Binding
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Tocotrienols have limited bioavailability due to their short half-life in the body, limiting their usefulness despite showing beneficial health effects, as they have a lower binding affinity to αTTP compared to tocopherols, which are more efficiently transported out of the liver and into the bloodstream.
Innovation Solution
Development of tocoflexols, which are derivatives of tocopherols and tocotrienols with modifications to the hydrocarbon tail to enhance binding and uptake by αTTP, using a novel and economical synthetic route that utilizes partially purified tocotrienol preparations from natural sources, allowing for increased flexibility and longer half-life in the body.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If tocotrienols are used as dietary supplements, then beneficial health effects are achieved, but bioavailability is limited due to short half-life and lower binding affinity to αTTP
Solution Approach 1:
The patent modifies the hydrocarbon tail parameters of tocotrienols by introducing flexible alkyl chains with specific saturation levels (0-3 double bonds) and lengths (C5-C20), transforming the rigid tail structure into a flexible one that optimizes binding affinity to αTTP and extends half-life in the body
Solution Approach 2:
The patent creates composite molecular structures by combining the tocotrienol core with modified hydrocarbon tails featuring specific functional groups and saturation patterns, resulting in hybrid molecules (tocoflexols) that exhibit both the antioxidant properties of tocotrienols and the extended circulation half-life of tocopherols
2Manufacturing precision
If pure tocotrienols are separated from natural sources, then high purity is achieved, but production cost increases significantly
Solution Approach 1:
The patent applies partial purification to natural sources containing tocotrienols, accepting that the starting material is not fully pure but contains sufficient tocotrienol content (at least 5% by weight) to proceed with the modification reaction, thereby avoiding the expensive complete purification step while maintaining adequate reaction efficiency
Solution Approach 2:
The patent uses inexpensive, readily available natural sources (such as palm oil, annatto oil, or wheat germ oil) that contain tocotrienols in partially purified form, treating these materials as cost-effective starting points that do not require expensive purification infrastructure or processes
3Duration of action of moving object
If tocopherols are used instead of tocotrienols, then efficient transport and longer half-life are achieved, but certain beneficial health effects seen with tocotrienols are lost
Solution Approach 1:
The patent designs tocoflexol molecules that perform multiple functions: they retain the antioxidant and anti-inflammatory properties of tocotrienols while simultaneously achieving the efficient αTTP-mediated transport and extended half-life characteristic of tocopherols, thus combining the beneficial effects of both molecule types into a single compound
Data Source
AI summary
Methods for the synthesis of tocoflexols of Formula (I) and (II) and a number of related tocol analogs are provided herein. The methods are economical and amenable to large scale production and can be performed using either pure of partially purified tocotrienols as the starting material.